The aggregation of an amyloid protein, a-synuclein (a-Syn), has been suggested as a potential cause of Parkinson's and several other neurodegenerative diseases. To explore the possibility of using nanoparticle-based therapeutic agents for the treatment of such diseases, we investigated the influence of surface chemistry and concentration of mesoporous silica nanoparticles (MSNPs) on the fibrillation of recombinant human a-Syn protein in the present work. Bare MSNPs as well as MSNPs of different surface functionalities, including 3-(2-aminoethyl amino) propyltrimethoxysilane (AAS), succinic anhydride (carboxyl), and polyethyleneimine (PEI) were prepared and characterized by electron microscopy, zeta potential measurement, Brunauer-Emmett-Teller (BET) isotherms, and FT-IR analyses.The process of a-Syn fibril formation was monitored by Thioflavin T (ThT) assay, atomic force microscopy (AFM) and fluorescence microscopy imaging. The conformation of a-Syn molecules in fibrillar forms and upon adsorption onto MSNPs was investigated by circular dichroism (CD) analysis, and an MTT assay was employed to evaluate the cytotoxicity effects of a-Syn fibrils on a PC12 cell line in the absence and presence of MSNPs. The synthesized MSNPs were spherical and monodisperse with an average size of 83 AE 6 nm. Our results showed that the fibril formation is reduced considerably in the presence of positively-charged MSNPs, i.e. AAS-and PEI-MSNPs, and is enhanced while treated with negatively-charged MSNPs, i.e. bare and carboxyl-MSNPs. Furthermore, it was also demonstrated that increasing the concentration of the MSNPs regardless of their surface chemistry results in greater effects on the fibril formation-promoting or inhibiting for negatively and positively-charged MSNPs respectively. Subsequently, the cytotoxicity of the formed aggregates was noticed to be significantly reduced in the presence of AAS-and PEI-MSNPs in comparison to that in the absence of these MSNPs.These results suggest that the electrostatic charges and concentration of MSNPs play important regulatory roles in the fibrillation process of a-Syn. Thus, the present study contributes towards the better understanding and control of protein fibrillation by nanoparticles which can lead to development of nanoparticle-mediated therapies.